$MLR
MILLER INDUSTRIES INC /TN/

2024 Q1 Form 10-K Financial Statement

#000155837024002625 Filed on March 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $349.9M $296.2M $1.153B
YoY Change 23.95% 31.17% 35.94%
Cost Of Revenue $305.6M $257.6M $1.002B
YoY Change 21.35% 28.59% 30.74%
Gross Profit $44.24M $38.64M $151.9M
YoY Change 45.45% 51.38% 84.25%
Gross Profit Margin 12.65% 13.04% 13.17%
Selling, General & Admin $21.54M $16.37M $73.09M
YoY Change 20.19% 24.77% 38.35%
% of Gross Profit 48.69% 42.36% 48.13%
Research & Development $6.000M
YoY Change 48.88%
% of Gross Profit 3.95%
Depreciation & Amortization $3.506M $3.563M $13.24M
YoY Change 11.37% 13.69% 12.59%
% of Gross Profit 7.92% 9.22% 8.72%
Operating Expenses $21.54M $16.37M $79.09M
YoY Change 20.19% 24.77% 39.1%
Operating Profit $22.70M $22.27M $72.77M
YoY Change 81.7% 79.51% 184.67%
Interest Expense $1.245M -$666.0K $5.974M
YoY Change 23.02% -22.83% 76.8%
% of Operating Profit 5.48% -2.99% 8.21%
Other Income/Expense, Net $233.0K -$634.0K $191.0K
YoY Change -1265.0% -854.76% 1.6%
Pretax Income $21.49M $20.97M $73.78M
YoY Change 82.12% 80.36% 186.74%
Income Tax $4.465M $4.279M $15.49M
% Of Pretax Income 20.78% 20.4% 21.0%
Net Earnings $17.02M $16.70M $58.29M
YoY Change 84.63% 79.67% 186.5%
Net Earnings / Revenue 4.87% 5.64% 5.05%
Basic Earnings Per Share $1.49 $5.10
Diluted Earnings Per Share $1.47 $1.45 $5.07
COMMON SHARES
Basic Shares Outstanding 11.45M 11.45M 11.44M
Diluted Shares Outstanding 11.56M 11.51M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.81M $29.91M $29.91M
YoY Change -9.79% -25.51% -25.51%
Cash & Equivalents $26.80M $29.91M $29.91M
Short-Term Investments
Other Short-Term Assets $8.843M $4.617M $4.617M
YoY Change 30.6% 0.9% 0.9%
Inventory $184.3M $189.8M $189.8M
Prepaid Expenses $8.843M $4.617M
Receivables $338.9M $286.1M $286.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $558.8M $510.5M $510.5M
YoY Change 28.75% 35.75% 35.75%
LONG-TERM ASSETS
Property, Plant & Equipment $116.2M $115.1M $115.9M
YoY Change 4.68% 2.61% 2.52%
Goodwill $20.02M $20.02M
YoY Change 72.32% 72.32%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $786.0K $819.0K $819.0K
YoY Change 14.58% 15.68% 15.68%
Total Long-Term Assets $137.7M $136.7M $136.7M
YoY Change 10.95% 9.06% 9.06%
TOTAL ASSETS
Total Short-Term Assets $558.8M $510.5M $510.5M
Total Long-Term Assets $137.7M $136.7M $136.7M
Total Assets $696.5M $647.2M $647.2M
YoY Change 24.79% 29.07% 29.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $229.0M $191.8M $191.8M
YoY Change 35.16% 52.81% 52.81%
Accrued Expenses $43.51M $40.79M $35.01M
YoY Change 43.77% 46.19% 25.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $274.6M $234.7M $234.7M
YoY Change 34.12% 50.32% 50.32%
LONG-TERM LIABILITIES
Long-Term Debt $55.00M $60.00M $60.00M
YoY Change 22.22% 33.33% 33.33%
Other Long-Term Liabilities $426.0K $506.0K $506.0K
YoY Change -25.13% -15.24% -15.24%
Total Long-Term Liabilities $55.00M $60.00M $60.51M
YoY Change 22.22% 33.33% 32.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $274.6M $234.7M $234.7M
Total Long-Term Liabilities $55.00M $60.00M $60.51M
Total Liabilities $334.2M $299.3M $299.3M
YoY Change 30.28% 43.91% 43.91%
SHAREHOLDERS EQUITY
Retained Earnings $215.0M $200.2M
YoY Change 36.7% 33.33%
Common Stock $115.0K $114.0K
YoY Change 0.88% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $362.4M $347.9M $347.9M
YoY Change
Total Liabilities & Shareholders Equity $696.5M $647.2M $647.2M
YoY Change 24.79% 29.07% 29.07%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $17.02M $16.70M $58.29M
YoY Change 84.63% 79.67% 186.5%
Depreciation, Depletion And Amortization $3.506M $3.563M $13.24M
YoY Change 11.37% 13.69% 12.59%
Cash From Operating Activities $8.977M $6.753M $10.96M
YoY Change -232.72% -45.75% -157.23%
INVESTING ACTIVITIES
Capital Expenditures $4.672M $2.367M $12.10M
YoY Change 167.12% -37.91% -58.2%
Acquisitions
YoY Change
Other Investing Activities $9.000K $792.0K -$16.98M
YoY Change -212325.0%
Cash From Investing Activities -$4.663M -$1.565M -$29.08M
YoY Change 166.61% -58.95% 0.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.179M -2.069M 6.751M
YoY Change 248.66% 0.68% -81.64%
NET CHANGE
Cash From Operating Activities 8.977M 6.753M 10.96M
Cash From Investing Activities -4.663M -1.565M -29.08M
Cash From Financing Activities -7.179M -2.069M 6.751M
Net Change In Cash -3.100M 3.119M -10.24M
YoY Change -70.29% -52.6% -27.75%
FREE CASH FLOW
Cash From Operating Activities $8.977M $6.753M $10.96M
Capital Expenditures $4.672M $2.367M $12.10M
Free Cash Flow $4.305M $4.386M -$1.134M
YoY Change -150.57% -49.21% -97.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000924822
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-14124
CY2023 dei Entity Registrant Name
EntityRegistrantName
MILLER INDUSTRIES, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1566286
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
8503 Hilltop Drive,
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
8503 Hilltop Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Ooltewah
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2023 dei City Area Code
CityAreaCode
423
CY2023 dei Local Phone Number
LocalPhoneNumber
238-4171
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
CY2023 dei Trading Symbol
TradingSymbol
MLR
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
389950795
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11445640
CY2023 dei Auditor Firm
AuditorFirmId
149
CY2023 dei Auditor Location
AuditorLocation
Chattanooga, Tennessee
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29909000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1527000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1319000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
286138000
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
177663000
CY2023Q4 us-gaap Inventory Net
InventoryNet
189807000
CY2022Q4 us-gaap Inventory Net
InventoryNet
153656000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4617000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4576000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
510471000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
376048000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115072000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112145000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
826000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
909000
CY2023Q4 us-gaap Goodwill
Goodwill
20022000
CY2022Q4 us-gaap Goodwill
Goodwill
11619000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
819000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
708000
CY2023Q4 us-gaap Assets
Assets
647210000
CY2022Q4 us-gaap Assets
Assets
501429000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
191782000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
125500000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40793000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28333000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1819000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2001000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
320000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
234714000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
156145000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
60000000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45000000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
506000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
597000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4070000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6230000
CY2023Q4 us-gaap Liabilities
Liabilities
299290000
CY2022Q4 us-gaap Liabilities
Liabilities
207972000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11445640
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11416716
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
114000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
114000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153574000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152392000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
200165000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
150124000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5933000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9173000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
347920000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293457000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
647210000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
501429000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1153354000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
848456000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
717476000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1001500000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
766037000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
647624000
CY2023 us-gaap Gross Profit
GrossProfit
151854000
CY2022 us-gaap Gross Profit
GrossProfit
82419000
CY2021 us-gaap Gross Profit
GrossProfit
69852000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73087000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52827000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46233000
CY2023 us-gaap Interest Expense
InterestExpense
5974000
CY2022 us-gaap Interest Expense
InterestExpense
3379000
CY2021 us-gaap Interest Expense
InterestExpense
1355000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
991000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-481000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-498000
CY2023 mlr Operating And Nonoperating Income Expense
OperatingAndNonoperatingIncomeExpense
78070000
CY2022 mlr Operating And Nonoperating Income Expense
OperatingAndNonoperatingIncomeExpense
56687000
CY2021 mlr Operating And Nonoperating Income Expense
OperatingAndNonoperatingIncomeExpense
48086000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73784000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25732000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21766000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15493000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5386000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5511000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.42
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.72
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.72
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.72
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11439000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11417000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11411000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11507000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11417000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11411000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3240000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4228000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2156000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3240000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4228000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2156000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
61531000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
16118000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14099000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278533000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
200000
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
8216000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2156000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284616000
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
200000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
743000
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
8220000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4228000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293457000
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
123000
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1273000
CY2023 mlr Adjustments To Additional Paid In Capital Shares Withheld Related To Net Share Settlements
AdjustmentsToAdditionalPaidInCapitalSharesWithheldRelatedToNetShareSettlements
-214000
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
8250000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3240000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
347920000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13243000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11762000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11036000
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
251000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
53000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
38000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
203000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8216000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
22000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6751000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36765000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8238000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1117000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
174000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-137000
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
123000
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
200000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
200000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1059000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
743000
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2181000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1061000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1012000
CY2023 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
105599000
CY2022 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
24345000
CY2021 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
12723000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30421000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40748000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32071000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-50000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1130000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2603000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-63000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-24000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-116000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64936000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4485000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
33939000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10996000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5137000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
400000
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
451000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
929000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-118000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10963000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19155000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15268000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12097000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28939000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9150000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
398000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
91000
CY2023 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
17376000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29075000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28931000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9059000
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
45000000
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8249000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8220000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2858000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1160000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10244000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54332000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57521000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14179000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3189000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29909000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40153000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54332000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
8092000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
3332000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1570000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18053000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1806000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5890000
CY2023 mlr Number Of Independent Distributor
NumberOfIndependentDistributor
74
CY2023 mlr Number Of Foreign Market Distributors
NumberOfForeignMarketDistributors
50
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Arial Narrow';font-size:12pt;font-weight:bold;">Use of Estimates </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:6pt 0pt 6pt 0pt;"><span style="font-family:'Arial Narrow';background:#ffffff;">The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates include: income tax accruals, the net realizable value of inventory, warranty accruals, allowance for expected credit losses, legal accruals, impairment testing to goodwill, other long-lived assets, stock-based compensation and valuations of the assets acquired and liabilities assumed in a business combination or asset acquisition, when applicable. Actual results could differ materially from those estimates. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the current economic environment and other relevant factors, as applicable. Management adjusts such estimates and assumptions when facts and circumstances dictate.</span><span style="font-family:'Arial Narrow';background:#ffffff;"> </span></p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1500000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1300000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
135920000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
124674000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
109346000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
200000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
200000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300000
mlr Contract Liability Settled
ContractLiabilitySettled
15000.0
CY2023 us-gaap Product Warranty Expense
ProductWarrantyExpense
4000000.0
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
3200000
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
2400000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
717476000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6000000.0
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4000000.0
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3600000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2098000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3076000
CY2023 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4048000
CY2022 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3237000
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3333000
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4215000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2813000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2098000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1153354000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
848456000
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
2200000
CY2023Q4 mlr Inventory Chassis Net Of Reserves
InventoryChassisNetOfReserves
29748000
CY2022Q4 mlr Inventory Chassis Net Of Reserves
InventoryChassisNetOfReserves
18604000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
89048000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
75934000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
47934000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40655000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23077000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18463000
CY2023Q4 us-gaap Inventory Net
InventoryNet
189807000
CY2022Q4 us-gaap Inventory Net
InventoryNet
153656000
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5600000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5900000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
217558000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
202382000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
102486000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
90237000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115072000
CY2023 us-gaap Depreciation
Depreciation
13200000
CY2022 us-gaap Depreciation
Depreciation
11800000
CY2021 us-gaap Depreciation
Depreciation
11000000.0
CY2022Q4 us-gaap Goodwill
Goodwill
11619000
CY2023Q4 us-gaap Goodwill
Goodwill
20022000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20847000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11370000
CY2023Q4 mlr Accrued Sales Related Expenses
AccruedSalesRelatedExpenses
5919000
CY2022Q4 mlr Accrued Sales Related Expenses
AccruedSalesRelatedExpenses
6310000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
5901000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
4155000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2813000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2098000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5313000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4400000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40793000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28333000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2181000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1061000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1026000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15493000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5386000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5511000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
65068000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
21572000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
10947000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8716000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
4160000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10819000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73784000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25732000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21766000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
14949000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3225000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1126000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
541000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
180000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
343000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2184000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
920000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3016000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17674000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4325000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4485000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1797000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
890000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
981000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
310000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
91000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
13000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
74000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
80000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
32000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.036
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.016
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.006
CY2022 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.253
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
307000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
268000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3169000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
2058000
CY2023Q4 mlr Deferred Tax Assets Research And Development
DeferredTaxAssetsResearchAndDevelopment
2316000
CY2022Q4 mlr Deferred Tax Assets Research And Development
DeferredTaxAssetsResearchAndDevelopment
1697000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1099000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
747000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6891000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4770000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
10701000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
10989000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
260000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
11000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10961000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11000000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4070000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
6230000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3700000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3700000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
22000
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022 mlr Finance Lease Cost
FinanceLeaseCost
15000
CY2021 mlr Finance Lease Cost
FinanceLeaseCost
23000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
365000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
387000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
419000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
368000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
592000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
493000
CY2023 us-gaap Lease Cost
LeaseCost
733000
CY2022 us-gaap Lease Cost
LeaseCost
994000
CY2021 us-gaap Lease Cost
LeaseCost
935000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
826000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
909000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
320000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
506000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
597000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
826000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
908000
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.035
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.031
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.040
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
365000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
387000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
419000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
22000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
117000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
143000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
360000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
306000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
139000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
30000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
24000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
869000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
826000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
160000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
29.95
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
160000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.95
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
18835
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.98
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
32000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.95
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
146835
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
33.98
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
3154000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
4392000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y2M12D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
958000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11438965
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11416667
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11410728
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2023 us-gaap Net Income Loss
NetIncomeLoss
58291000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
20346000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
16255000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11438965
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11416667
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11410728
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
67995000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11506960
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11416667
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11410728
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.42
CY2023 mlr Defined Contribution Plan Number Of Completed Period Of Services For Qualification For Plan
DefinedContributionPlanNumberOfCompletedPeriodOfServicesForQualificationForPlan
P90D
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.500
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.050
CY2023 mlr Defined Contribution Plan Employee Contributions Vesting Period
DefinedContributionPlanEmployeeContributionsVestingPeriod
P5Y
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1600000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1400000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1200000
CY2023 mlr Percent Of Impacted Accounts
PercentOfImpactedAccounts
3.6
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95293000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
121746000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137998000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97417000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88251000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
129959000
CY2024Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2024-03-04
CY2024Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.19
CY2024Q1 mlr Dividends Payable Amount Per Share Increase Over Prior Quarter
DividendsPayableAmountPerShareIncreaseOverPriorQuarter
0.01
CY2024Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2024-03-25
CY2024Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2024-03-18
CY2023 dei Auditor Name
AuditorName
Elliott Davis
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-002625-index-headers.html Edgar Link pending
0001558370-24-002625-index.html Edgar Link pending
0001558370-24-002625.txt Edgar Link pending
0001558370-24-002625-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlr-20231231.xsd Edgar Link pending
mlr-20231231x10k.htm Edgar Link pending
mlr-20231231x10k001.jpg Edgar Link pending
mlr-20231231x10k002.jpg Edgar Link pending
mlr-20231231x10k003.jpg Edgar Link pending
mlr-20231231x10k004.jpg Edgar Link pending
mlr-20231231x10k005.jpg Edgar Link pending
mlr-20231231x10k007.jpg Edgar Link pending
mlr-20231231xex10d9.htm Edgar Link pending
mlr-20231231xex21.htm Edgar Link pending
mlr-20231231xex23d1.htm Edgar Link pending
mlr-20231231xex23d1001.jpg Edgar Link pending
mlr-20231231xex31d1.htm Edgar Link pending
mlr-20231231xex31d2.htm Edgar Link pending
mlr-20231231xex32d1.htm Edgar Link pending
mlr-20231231xex32d2.htm Edgar Link pending
mlr-20231231xex97d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
mlr-20231231_cal.xml Edgar Link unprocessable
mlr-20231231_def.xml Edgar Link unprocessable
mlr-20231231_lab.xml Edgar Link unprocessable
mlr-20231231x10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mlr-20231231_pre.xml Edgar Link unprocessable